MedTrace Logo

Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus

NCT00532506 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2008-10-10

No results posted yet for this study

Summary

The purpose of this study is to evaluate the clinical efficacy and safety of SK-0403 in patients with Type2 Diabetes Mellitus

Conditions

Interventions

DRUG

SK-0403

Sponsors & Collaborators

  • Sanwa Kagaku Kenkyusho Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Ryuzo Kawamori, M.D. · Juntendo University School of Medicine, Dept. of Endocrinology and Metabolism

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00532506 on ClinicalTrials.gov